Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6349124rdf:typepubmed:Citationlld:pubmed
pubmed-article:6349124lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6349124lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:6349124lifeskim:mentionsumls-concept:C0002874lld:lifeskim
pubmed-article:6349124lifeskim:mentionsumls-concept:C1879316lld:lifeskim
pubmed-article:6349124lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:6349124pubmed:issue6lld:pubmed
pubmed-article:6349124pubmed:dateCreated1983-9-20lld:pubmed
pubmed-article:6349124pubmed:abstractTextRed blood cell (RBC) and platelet (PLT) transfusion requirements during the first 13 weeks after HLA-identical marrow transplantation were studied in 82 patients with aplastic anemia. On the average, patients were given 9 units of RBCs (1-82) and 44 units of PLTS (6-468). The greatest need for support was during the first 4 weeks postgrafting. A multivariate statistical analysis of 22 variables showed that RBC and PLT requirements increased with age. In addition, RBC requirements increased if the patient had isohemagglutinins against the marrow donor's RBC, i.e., if the marrow transplant was across a major ABO barrier.lld:pubmed
pubmed-article:6349124pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6349124pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6349124pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6349124pubmed:languageenglld:pubmed
pubmed-article:6349124pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6349124pubmed:citationSubsetIMlld:pubmed
pubmed-article:6349124pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6349124pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6349124pubmed:statusMEDLINElld:pubmed
pubmed-article:6349124pubmed:issn0042-9007lld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:StewartPPlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:StorbRRlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:ThomasE DEDlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:BucknerC DCDlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:SlichterSSlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:SandersJJlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:BanajiMMlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:CliftRRlld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:WulffJ CJClld:pubmed
pubmed-article:6349124pubmed:authorpubmed-author:SantnerT JTJlld:pubmed
pubmed-article:6349124pubmed:issnTypePrintlld:pubmed
pubmed-article:6349124pubmed:volume44lld:pubmed
pubmed-article:6349124pubmed:ownerNLMlld:pubmed
pubmed-article:6349124pubmed:authorsCompleteYlld:pubmed
pubmed-article:6349124pubmed:pagination366-74lld:pubmed
pubmed-article:6349124pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:meshHeadingpubmed-meshheading:6349124-...lld:pubmed
pubmed-article:6349124pubmed:year1983lld:pubmed
pubmed-article:6349124pubmed:articleTitleTransfusion requirements after HLA-identical marrow transplantation in 82 patients with aplastic anemia.lld:pubmed
pubmed-article:6349124pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6349124pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:6349124pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed